#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease Thrombotic thrombocytopenic purpura Kidney transplant rejection Cushing's syndrome Nephroblastoma Desmoid tumour Complex regional pain syndrome Partial lipodystrophy Myxofibrosarcoma Arteriosclerosis Spinal cord injury cervical Selective polysaccharide antibody deficiency Prolymphocytic leukaemia Pemphigus Myxoid liposarcoma More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Basic Information Hypereosinophilic syndrome – Life with Disease Hepatoblastoma – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease Hereditary optic atrophy – Life with Disease Synovial sarcoma metastatic – Diagnostics Burkitt’s lymphoma – Treatment Systemic mastocytosis Thrombotic thrombocytopenic purpura – Life with Disease VEXAS syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regn5668 MALIC ACID Bi 690517 Tetracosactide MB-001 IADADEMSTAT OBI-821 LIGUFALIMAB Pc14586 Semaglutide Tafamidis Hydrocortisone Acetate ETX-19477 Bupivacaine INCB123667 LUNRESERTIB Glenzocimab Emibetuzumab Levosimendan Eik1003 More therapies…

    Learn about Your Condition

    Prostate cancer Adrenoleukodystrophy Myasthenia gravis Pulmonary alveolar haemorrhage Supranuclear palsy Febrile neutropenia Skin cancer Major depression Diabetic foot Kawasaki's disease Biliary tract operation Thyroid cancer Pelizaeus-Merzbacher disease Suicidal ideation Cardiogenic shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specialized Eye Diseases Hospital For Active Treatment-Varna…

Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD

Ulitsa Doyran 15, Varna, 9002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Aflibercept
    Bulgaria Czechia Hungary Latvia Poland Slovakia

  • Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

    Recruiting

    3 1
    Investigated Drugs:
    • Oxymetazoline Hydrochloride
    Bulgaria Czechia France Germany Hungary Italy +4

  • A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus Monohydrate
    Bulgaria France Greece Italy Spain

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Atezolizumab
    • Lenvatinib
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Bulgaria Romania

  • Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    • Bevacizumab
    • Durvalumab
    Austria Belgium Bulgaria Denmark Finland France +6

  • Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Cilastatin
    • Imipenem Anhydrate
    • Tebipenem Pivoxil Hydrobromide
    Bulgaria Croatia Estonia Greece Hungary Latvia +3

  • Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Bulgaria Croatia Poland Slovakia

  • Study on the Effectiveness of Retifanlimab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Diacid Monohydrate
    • Pemetrexed Disodium
    • Retifanlimab
    Bulgaria Czechia

  • Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    Bulgaria Czechia Denmark Germany Ireland Italy +1
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!